Connect Biopharma Holdings reported total assets of $43.47M and total liabilities of $16.61M for the quarter ended Jun 2026, down 47.4% year over year. This balance sheet covers 17 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current Assets | |||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 154.87M | 313.32M | 267.87M | 141.37M | 79.03M | 81.61M | 105.66M | 110.20M | 78.23M | 47.71M | 40.63M | 37.85M | 38.35M | 46.03M | 27.02M | ||
| Short-term InvestmentsInvestments (Current) | 49.27M | 73.42M | 49.96M | 12.64M | 15.50M | 36.30M | 31.14M | 16.94M | 6.00M | 4.50M | |||||||
| Cash & Current Investments | 154.87M | 313.32M | 267.87M | 190.64M | 152.45M | 131.57M | 118.30M | 110.20M | 93.73M | 84.01M | 71.77M | 54.78M | 44.35M | 46.03M | 31.52M | ||
| Receivables - NetNet Receivables | 12.95M | 0.79M | 0.01M | 0.02M | 0.01M | 2.94M | |||||||||||
| Receivables - OtherOther Receivables | 0.27M | 0.33M | 0.43M | 0.23M | 3.10M | 3.56M | |||||||||||
| Receivables | 13.18M | 0.79M | 0.01M | 0.02M | 0.01M | 2.94M | |||||||||||
| Prepaid Assets | 4.30M | 11.29M | 5.79M | 4.52M | 2.71M | 2.28M | 4.25M | 2.16M | 2.46M | 3.75M | 5.99M | 7.80M | 6.57M | 8.99M | 4.20M | ||
| Current Assets | 162.03M | 324.76M | 275.28M | 197.76M | 155.81M | 138.17M | 122.55M | 115.90M | 96.96M | 87.76M | 77.76M | 62.60M | 50.93M | 55.02M | 38.62M | ||
| Non-Current Assets | |||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 1.06M | 3.80M | 9.31M | 9.94M | 4.98M | 4.52M | 4.27M | 4.20M | 4.05M | 3.91M | 4.05M | 3.94M | 3.81M | 3.70M | 3.60M | ||
| Long-Term Investments | 2.00M | 22.30M | 9.44M | 0.19M | 0.93M | 0.83M | 0.74M | 0.65M | 0.65M | 0.56M | |||||||
| Intangibles | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | |||||||||
| Goodwill & Intangibles | 0.05M | 0.04M | 0.09M | 0.08M | 0.07M | 0.07M | 0.06M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | ||
| Long-Term Deferred Tax | 0.45M | 0.32M | |||||||||||||||
| Other Non-Current Assets | 3.04M | 4.28M | 2.95M | 0.84M | 0.25M | 0.74M | 0.02M | 0.10M | 0.03M | 0.05M | 0.05M | 0.05M | 0.65M | 0.65M | 0.65M | ||
| Non-Current Assets | 4.30M | 11.73M | 15.93M | 36.93M | 18.23M | 5.91M | 4.92M | 4.67M | 4.32M | 4.93M | 4.97M | 4.76M | 5.15M | 5.05M | 4.85M | ||
| Assets | 166.33M | 336.49M | 291.22M | 234.70M | 174.05M | 144.08M | 127.38M | 120.57M | 101.28M | 92.69M | 82.73M | 67.36M | 56.08M | 60.07M | 43.47M | ||
| Liabilities | |||||||||||||||||
| Current Liabilities | |||||||||||||||||
| Accounts Payables | 3.78M | 10.16M | 12.74M | 15.14M | 11.94M | 11.52M | 2.21M | 5.70M | 0.34M | 0.82M | 2.29M | 1.99M | 1.96M | 4.31M | 2.02M | ||
| Payables | 3.78M | 10.16M | 12.74M | 15.14M | 11.94M | 11.52M | 2.21M | 5.70M | 0.34M | 0.82M | 2.29M | 1.99M | 1.96M | 4.31M | 2.02M | ||
| Accumulated Expenses | 9.48M | 7.80M | 7.24M | 7.93M | 8.93M | 11.16M | 12.33M | 13.89M | |||||||||
| Other Accumulated Expenses | 1.96M | 3.77M | 5.15M | 5.28M | 3.50M | 3.14M | 3.00M | 3.67M | |||||||||
| Current Leases | 0.29M | 0.15M | 0.35M | 0.35M | 0.34M | 0.32M | 0.41M | 0.39M | |||||||||
| Current Deferred Revenue | 0.78M | 0.72M | 0.65M | 0.16M | 13.32M | 0.16M | 0.16M | 0.16M | 0.17M | 0.17M | |||||||
| Current Deferred Tax LiabilityCurrent Deferred Tax | 0.25M | ||||||||||||||||
| Total Current Liabilities | 5.83M | 14.03M | 17.99M | 20.65M | 15.63M | 14.93M | 25.29M | 9.62M | 8.46M | 8.57M | 10.74M | 11.43M | 13.61M | 17.05M | 16.30M | ||
| Non-Current Liabilities | |||||||||||||||||
| Non-Current Deferred Revenue | 0.41M | 0.63M | |||||||||||||||
| Operating Leases | 0.05M | 0.08M | 0.03M | 0.34M | 0.24M | 0.32M | 0.18M | 0.07M | 0.02M | 0.59M | 0.52M | 0.45M | 0.37M | 0.29M | 0.20M | ||
| Other Non-Current Liabilities | 7.33M | 0.41M | 0.63M | 0.63M | 0.12M | 0.12M | 0.11M | 0.11M | 0.11M | ||||||||
| Total Non-Current Liabilities | 317.66M | 0.08M | 0.81M | 1.05M | 0.90M | 0.49M | 0.59M | 0.47M | 8.49M | 9.16M | 11.26M | 11.87M | 13.98M | 17.33M | 16.50M | ||
| Total Liabilities | 323.48M | 14.25M | 18.81M | 21.70M | 16.52M | 15.42M | 25.88M | 9.64M | 9.12M | 9.79M | 11.38M | 11.99M | 14.10M | 17.44M | 16.61M | ||
| Shareholder's Equity | |||||||||||||||||
| Common Equity | -157.15M | 322.23M | 272.41M | 212.99M | 157.53M | 128.67M | 101.50M | 93.90M | 110.93M | 100.65M | 92.17M | 82.90M | 71.34M | 55.37M | 41.98M | 42.62M | 26.86M |
| Liabilities and Shareholders Equity | 166.33M | 336.49M | 291.22M | 234.70M | 174.05M | 144.08M | 127.38M | 120.57M | 101.28M | 92.69M | 82.73M | 67.36M | 56.08M | 60.07M | 43.47M | ||
| Treasury Stock | 459.97 | -464.17 | 0.18M | 0.17M | 0.17M | 0.16M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | ||
| Retained Earnings | -164.26M | -311.73M | -373.22M | -414.14M | -456.01M | -468.76M | -329.73M | -531.70M | -345.36M | -355.63M | -368.53M | -385.73M | -400.84M | -420.23M | -437.52M | ||
| Treasury Shares | -0.18M | 2.41M | 2.51M | 2.15M |
Pull Connect Biopharma Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CNTB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CNTB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CNTB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();